• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Pacific Biometrics, Inc. Hires David W. Swezey As New Lab Manager; Mr. Swezey Brings 25 Years of Management Experience in Clinical Laboratories

Posted on: Tuesday, 23 May 2006, 16:57 CDT

Pacific Biometrics, Inc. (OTCBB: PBME; "PBI") has appointed David W. Swezey as its new Lab Manager. Mr. Swezey has 25 years of progressive management experience in the clinical laboratory industry. He previously served as PBI's Quality Assurance (QA) Manager from 2000 through 2003 and its Technical Supervisor from 1997 to 2000. Now, as Lab Manager, Mr. Swezey will oversee and direct the operation of all laboratory functions, including coordination with the Science and Technology group for the improvement and implementation of analytical methods.

"We are excited to have Mr. Swezey take over the management of the PBI laboratory, which provides the primary basis for our company's business," said Ronald R. Helm, Chairman, Chief Executive Officer and President. "With his scientific training and extensive background performing and supervising a vast array of laboratory functions, Mr. Swezey is clearly qualified to help PBI continue to provide specialized central laboratory and contract services in support of many of the world's largest pharmaceutical, biotech and diagnostic companies."

Mr. Swezey, who has a degree in biology from Humboldt State University and a Clinical Laboratory Scientist certification from the School of Medical Technology at Santa Barbara Cottage Hospital, spent the last two years as Clinical Laboratory Manager of Sterling Reference Laboratories, where he was responsible for the management of all operations in clinical and toxicology laboratories. Prior, as QA Manager at PBI, Mr. Swezey created the Company laboratory's new QA department, and implemented systems compliant with Collage of American Pathologists and Good Laboratory Practices regulations. As Technical Supervisor for the Company, he was responsible for all technical aspects of testing, including the management of quality-control systems, the development of new methodologies, and the improvement of existing assays for increased efficiency.

About Pacific Biometrics, Inc.

Established in 1989, PBI provides specialized central laboratory and contract research services to support pharmaceutical and diagnostic manufacturers conducting human clinical trial research. The company provides expert services in the areas of cardiovascular disease, diabetes, osteoporosis, arthritis, and nutrition. The PBI laboratory is accredited by the College of American Pathologists, and through its non-profit affiliate Pacific Biometrics Research Foundation, is one of only three U.S.-based members of the Centers for Disease Control (CDC) Cholesterol Reference Method Laboratory Network. PBI's clients include many of the world's largest pharmaceutical, biotech, and diagnostic companies.

Pacific Biometrics also owns several patented and patent-pending technologies, including monitoring devices for glucose and changes in bone turnover, an advanced, proprietary, isothermal DNA amplification technology, and a gene-based cell viability technology to distinguish live from dead cells in a broad range of diagnostic applications.

For more information, visit the Company Web site at www.pacbio.com.

Source: Business Wire

More News in this Category